Previously Director of Business Development at One Nucleus, 2017 saw Tony take charge of One Nucleus at an exciting time as the sector seeks to implement the UK Industrial Strategy for Life Sciences, Brexit on the horizon and an ever changing landscape in the USA.

After completing a PhD in Biochemistry from the University of Southampton UK, Tony undertook several years of post-doctoral research in the oncology field, primarily with the Imperial Cancer Research Fund. In 1997, he moved into Technology Transfer with the Medical Research Council and later University College London, at the Wolfson Institute for Biomedical Research. In November 2003, Tony took up the post of Director of Biotechnology & Healthcare at London First.